Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion type Assertion NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_head.
- NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion description "[The antitumour effect of OBP-702 was compared to that of OBP-301 on OBP-301-sensitive (H358 and H460) and OBP-301-resistant (T.Tn and HSC4) human cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_provenance.
- NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion evidence source_evidence_literature NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_provenance.
- NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion SIO_000772 22244827 NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_provenance.
- NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion wasDerivedFrom befree-20150227 NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_provenance.
- NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_assertion wasGeneratedBy ECO_0000203 NP526850.RARZeKMFzdP2SyzEWIpMA6_p47Eg58ka7mcMxh25IqLEs130_provenance.